| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
American Journal of Pathology, Vol 146, 33-39, Copyright © 1995 by American Society for Investigative Pathology
REGULAR ARTICLES |
HD Foss, M Hummel, S Gottstein, K Ziemann, B Falini, H Herbst and H Stein
Institute of Pathology, Benjamin Franklin Clinic, Free University of Berlin, Germany.
Interleukin-7 (IL-7) is a pleiotropic cytokine acting mainly on cells of the hematolymphoid system. In vitro studies have shown enhanced proliferation of acute lymphoblastic leukemia cells in response to IL- 7. On the other hand, tumor cell lines transfected with a functioning IL-7 gene and subsequently transplanted into mice resulted in a prominent inflammatory infiltrate and reduced tumorigeneicity. These data suggest an important role of this cytokine in the pathophysiology of lymphoid neoplasms. Because little is known about the in vivo expression of this cytokine in various neoplastic and nonneoplastic lesions of the lymphoid system, we examined frozen and paraffin- embedded tissue samples of normal, reactive, and malignant lymphoid lesions using in situ hybridization with a 35S-labeled RNA probe specific for IL-7. Tumor cells of nodular sclerosing and mixed cellularity type of Hodgkin's disease displayed IL-7-specific signals in 24 of 31 cases. Among reactive lesions, only thymic tissue showed labeling within both cortex and medulla (4 of 7 cases), whereas in tonsils clear-cut IL-7-specific signals could not be found. Tissues infiltrated by B-type chronic lymphocytic leukemia or T- or B-type lymphoblastic lymphoma showed cytokine-specific signals in only one case of lymphoblastic lymphoma in rare reactive cells. In conjunction with the finding of elevated levels of IL-7 in the serum of many patients with Hodgkin's disease, our data suggest an important role of this cytokine in the pathogenesis of Hodgkin's disease. The prominent reactive infiltrate observed in most cases of Hodgkin's disease could be a consequence of elevated local levels of this cytokine as similar infiltrates are also observed in tumors in mice resulting from injection of tumor cell lines transfected with a functioning IL-7 gene.
This article has been cited by other articles:
![]() |
K. A. Duthie, L. C. Osborne, L. J. Foster, and N. Abraham Proteomics Analysis of Interleukin (IL)-7-induced Signaling Effectors Shows Selective Changes in IL-7R{alpha}449F Knock-in T Cell Progenitors Mol. Cell. Proteomics, October 1, 2007; 6(10): 1700 - 1710. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Shulga-Morskoy and B.E. Rich Bioactive IL7-diphtheria fusion toxin secreted by mammalian cells Protein Eng. Des. Sel., January 1, 2005; 18(1): 25 - 31. [Abstract] [Full Text] [PDF] |
||||
![]() |
V. I. Brown, J. Fang, K. Alcorn, R. Barr, J. M. Kim, R. Wasserman, and S. A. Grupp Rapamycin is active against B-precursor leukemia in vitro and in vivo, an effect that is modulated by IL-7-mediated signaling PNAS, December 9, 2003; 100(25): 15113 - 15118. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. MULLER, P. REITERER, U. E. HOPKEN, S. GOLFIER, and M. LIPP Role of Homeostatic Chemokine and Sphingosine-1-Phosphate Receptors in the Organization of Lymphoid Tissue Ann. N.Y. Acad. Sci., April 1, 2003; 987(1): 107 - 116. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. F. Skinnider and T. W. Mak The role of cytokines in classical Hodgkin lymphoma Blood, May 29, 2002; 99(12): 4283 - 4297. [Abstract] [Full Text] [PDF] |
||||
![]() |
U. E. Hopken, H.-D. Foss, D. Meyer, M. Hinz, K. Leder, H. Stein, and M. Lipp Up-regulation of the chemokine receptor CCR7 in classical but not in lymphocyte-predominant Hodgkin disease correlates with distinct dissemination of neoplastic cells in lymphoid organs Blood, February 15, 2002; 99(4): 1109 - 1116. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. F. Skinnider, A. J. Elia, R. D. Gascoyne, B. Patterson, L. Trumper, U. Kapp, and T. W. Mak Signal transducer and activator of transcription 6 is frequently activated in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma Blood, January 15, 2002; 99(2): 618 - 626. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Oelmann, H. Herbst, M. Zuhlsdorf, O. Albrecht, A. Nolte, C. Schmitmann, O. Manzke, V. Diehl, H. Stein, and W. E. Berdel Tissue inhibitor of metalloproteinases 1 is an autocrine and paracrine survival factor, with additional immune-regulatory functions, expressed by Hodgkin/Reed-Sternberg cells Blood, January 1, 2002; 99(1): 258 - 267. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Emmerich, M. Meiser, M. Hummel, G. Demel, H.-D. Foss, F. Jundt, S. Mathas, D. Krappmann, C. Scheidereit, H. Stein, et al. Overexpression of I Kappa B Alpha Without Inhibition of NF-kappa B Activity and Mutations in the I Kappa B Alpha Gene in Reed-Sternberg Cells Blood, November 1, 1999; 94(9): 3129 - 3134. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Jundt, I. Anagnostopoulos, K. Bommert, F. Emmerich, G. Muller, H.-D. Foss, H.-D. Royer, H. Stein, and B. Dorken Hodgkin/Reed-Sternberg Cells Induce Fibroblasts to Secrete Eotaxin, a Potent Chemoattractant for T Cells and Eosinophils Blood, September 15, 1999; 94(6): 2065 - 2071. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |